Drug intelligence / Profile preview

Obadex

Development stage
Unknown
Lead developer
SKT Healthcare
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Obadex is a combination ophthalmic pharmaceutical product marketed by SKT Healthcare. It consists of the aminoglycoside antibiotic tobramycin and the potent synthetic glucocorticoid dexamethasone. This combination is indicated for the treatment of steroid-responsive inflammatory ocular conditions where a bacterial infection or a risk of bacterial ocular infection exists, such as uveitis, eye injury, radiation-induced inflammation, or chemical burns. Tobramycin provides bactericidal activity by binding to the bacterial 30S ribosomal subunit, thereby inhibiting protein synthesis. Dexamethasone acts as a glucocorticoid receptor agonist to suppress the inflammatory response, reducing edema, capillary dilation, and fibrin deposition. The product is formulated as eye drops for topical ophthalmic administration.

Brand names
Obadex
Other names
tobramycin + dexamethasone
02

Targets

GR (Glucocorticoid receptor)Bacterial Ribosome

Beyond the preview

Go deeper on Obadex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Obadex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call